{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:58:36Z","timestamp":1790855916409,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Oslo University Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00259-017-3843-9","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T08:02:55Z","timestamp":1507795375000},"page":"218-225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["The prognostic value of 18F\u2013FDG PET\/CT prior to liver transplantation for nonresectable colorectal liver metastases"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9271-8789","authenticated-orcid":false,"given":"Harald","family":"Grut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svein","family":"Dueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l Dag","family":"Line","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona Elisabeth","family":"Revheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,12]]},"reference":[{"key":"3843_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2147\/CLEP.S34285","volume":"4","author":"GP Kanas","year":"2012","unstructured":"Kanas GP, Taylor A, Primrose JN, Langeberg WJ, Kelsh MA, Mowat FS, et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol. 2012;4:283\u2013301. \nhttps:\/\/doi.org\/10.2147\/CLEP.S34285\n\n.","journal-title":"Clin Epidemiol"},{"key":"3843_CR2","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693\u20139. \nhttps:\/\/doi.org\/10.1056\/NEJM199603143341104\n\n.","journal-title":"N Engl J Med"},{"key":"3843_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","volume":"10","author":"V Mazzaferro","year":"2009","unstructured":"Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10:35\u201343. \nhttps:\/\/doi.org\/10.1016\/S1470-2045(08)70284-5\n\n.","journal-title":"Lancet Oncol"},{"key":"3843_CR4","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.cld.2011.08.004","volume":"15","author":"HC Masuoka","year":"2011","unstructured":"Masuoka HC, Rosen CB. Transplantation for cholangiocarcinoma. Clin Liver Dis. 2011;15:699\u2013715. \nhttps:\/\/doi.org\/10.1016\/j.cld.2011.08.004\n\n.","journal-title":"Clin Liver Dis"},{"key":"3843_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/jso.21415","volume":"101","author":"KK Lee","year":"2010","unstructured":"Lee KK, Kim DG, Moon IS, Lee MD, Park JH. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol. 2010;101:47\u201353. \nhttps:\/\/doi.org\/10.1002\/jso.21415\n\n.","journal-title":"J Surg Oncol"},{"key":"3843_CR6","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/SLA.0b013e31828ee17c","volume":"257","author":"YP Treut Le","year":"2013","unstructured":"Le Treut YP, Gregoire E, Klempnauer J, Belghiti J, Jouve E, Lerut J, et al. Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg. 2013;257:807\u201315. \nhttps:\/\/doi.org\/10.1097\/SLA.0b013e31828ee17c\n\n.","journal-title":"Ann Surg"},{"key":"3843_CR7","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/j.1432-2277.2008.00735.x","volume":"21","author":"E Hoti","year":"2008","unstructured":"Hoti E, Adam R. Liver transplantation for primary and metastatic liver cancers. Transpl Int. 2008;21:1107\u201317. \nhttps:\/\/doi.org\/10.1111\/j.1432-2277.2008.00735.x\n\n.","journal-title":"Transpl Int"},{"key":"3843_CR8","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/SLA.0b013e3182823957","volume":"257","author":"M Hagness","year":"2013","unstructured":"Hagness M, Foss A, Line PD, Scholz T, Jorgensen PF, Fosby B, et al. Liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg. 2013;257:800\u20136. \nhttps:\/\/doi.org\/10.1097\/SLA.0b013e3182823957\n\n.","journal-title":"Ann Surg"},{"key":"3843_CR9","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.crad.2011.07.046","volume":"66","author":"RH Briggs","year":"2011","unstructured":"Briggs RH, Chowdhury FU, Lodge JP, Scarsbrook AF. Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer. Clin Radiol. 2011;66:1167\u201374. \nhttps:\/\/doi.org\/10.1016\/j.crad.2011.07.046\n\n.","journal-title":"Clin Radiol"},{"key":"3843_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.critrevonc.2010.04.011","volume":"77","author":"M Lin","year":"2011","unstructured":"Lin M, Wong K, Ng WL, Shon IH, Morgan M. Positron emission tomography and colorectal cancer. Crit Rev Oncol Hematol. 2011;77:30\u201347. \nhttps:\/\/doi.org\/10.1016\/j.critrevonc.2010.04.011\n\n.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3843_CR11","volume-title":"National Comprehensive Cancer Network (NCCN) Guidelines Version 32017 Colon and Rectal Cancer","author":"Network NCC","year":"2017","unstructured":"Network NCC. National Comprehensive Cancer Network (NCCN) Guidelines Version 32017 Colon and Rectal Cancer 2017."},{"key":"3843_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1148\/radiol.2371042060","volume":"237","author":"S Bipat","year":"2005","unstructured":"Bipat S, van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, Zwinderman AH, et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis. Radiology. 2005;237:123\u201331. \nhttps:\/\/doi.org\/10.1148\/radiol.2371042060\n\n.","journal-title":"Radiology"},{"key":"3843_CR13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00259-014-2930-4","volume":"42","author":"AM Maffione","year":"2015","unstructured":"Maffione AM, Lopci E, Bluemel C, Giammarile F, Herrmann K, Rubello D. Diagnostic accuracy and impact on management of (18)F-FDG PET and PET\/CT in colorectal liver metastasis: a meta-analysis and systematic review. Eur J Nucl Med Mol Imaging. 2015;42:152\u201363. \nhttps:\/\/doi.org\/10.1007\/s00259-014-2930-4\n\n.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3843_CR14","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/SLA.0b013e31821110c9","volume":"253","author":"S Patel","year":"2011","unstructured":"Patel S, McCall M, Ohinmaa A, Bigam D, Dryden DM. Positron emission tomography\/computed tomographic scans compared to computed tomographic scans for detecting colorectal liver metastases: a systematic review. Ann Surg. 2011;253:666\u201371. \nhttps:\/\/doi.org\/10.1097\/SLA.0b013e31821110c9\n\n.","journal-title":"Ann Surg"},{"key":"3843_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1477-7819-12-26","volume":"12","author":"SE Ozis","year":"2014","unstructured":"Ozis SE, Soydal C, Akyol C, Can N, Kucuk ON, Yagci C, et al. The role of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in the primary staging of rectal cancer. World J Surg Oncol. 2014;12:26. \nhttps:\/\/doi.org\/10.1186\/1477-7819-12-26\n\n.","journal-title":"World J Surg Oncol"},{"key":"3843_CR16","first-page":"1431","volume":"45","author":"JA Thie","year":"2004","unstructured":"Thie JA. Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med. 2004;45:1431\u20134.","journal-title":"J Nucl Med"},{"key":"3843_CR17","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1097\/rlu.0000000000000744","volume":"40","author":"HH Tam","year":"2015","unstructured":"Tam HH, Cook GJ, Chau I, Drake B, Zerizer I, Du Y, et al. The role of routine clinical pretreatment 18F-FDG PET\/CT in predicting outcome of colorectal liver metastasis. Clin Nucl Med. 2015;40:e259\u201364. \nhttps:\/\/doi.org\/10.1097\/rlu.0000000000000744\n\n.","journal-title":"Clin Nucl Med"},{"key":"3843_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40644-015-0055-z","volume":"15","author":"Q Xia","year":"2015","unstructured":"Xia Q, Liu J, Wu C, Song S, Tong L, Huang G, et al. Prognostic significance of (18)FDG PET\/CT in colorectal cancer patients with liver metastases: a meta-analysis. Cancer Imaging. 2015;15:19. \nhttps:\/\/doi.org\/10.1186\/s40644-015-0055-z\n\n.","journal-title":"Cancer Imaging"},{"key":"3843_CR19","doi-asserted-by":"publisher","first-page":"787","DOI":"10.7150\/thno.5629","volume":"3","author":"B Bai","year":"2013","unstructured":"Bai B, Bading J, Conti PS. Tumor quantification in clinical positron emission tomography. Theranostics. 2013;3:787\u2013801. \nhttps:\/\/doi.org\/10.7150\/thno.5629\n\n.","journal-title":"Theranostics"},{"key":"3843_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1245\/s10434-009-0719-7","volume":"17","author":"SH Hyun","year":"2010","unstructured":"Hyun SH, Choi JY, Shim YM, Kim K, Lee SJ, Cho YS, et al. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Ann Surg Oncol. 2010;17:115\u201322. \nhttps:\/\/doi.org\/10.1245\/s10434-009-0719-7\n\n.","journal-title":"Ann Surg Oncol"},{"key":"3843_CR21","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1097\/MEG.0b013e328323d6fa","volume":"21","author":"L Pan","year":"2009","unstructured":"Pan L, Gu P, Huang G, Xue H, Wu S. Prognostic significance of SUV on PET\/CT in patients with esophageal cancer: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2009;21:1008\u201315. \nhttps:\/\/doi.org\/10.1097\/MEG.0b013e328323d6fa\n\n.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3843_CR22","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.ejcts.2008.07.023","volume":"34","author":"N Al-Sarraf","year":"2008","unstructured":"Al-Sarraf N, Gately K, Lucey J, Aziz R, Doddakula K, Wilson L, et al. Clinical implication and prognostic significance of standardised uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases. Eur J Cardiothorac Surg. 2008;34:892\u20137. \nhttps:\/\/doi.org\/10.1016\/j.ejcts.2008.07.023\n\n.","journal-title":"Eur J Cardiothorac Surg"},{"key":"3843_CR23","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1200\/JCO.2004.11.109","volume":"22","author":"RJ Downey","year":"2004","unstructured":"Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S, et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol. 2004;22:3255\u201360. \nhttps:\/\/doi.org\/10.1200\/JCO.2004.11.109\n\n.","journal-title":"J Clin Oncol"},{"key":"3843_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11548-012-0749-7","volume":"8","author":"H Zhang","year":"2013","unstructured":"Zhang H, Wroblewski K, Appelbaum D, Pu Y. Independent prognostic value of whole-body metabolic tumor burden from FDG-PET in non-small cell lung cancer. Int J Comput Assist Radiol Surg. 2013;8:181\u201391. \nhttps:\/\/doi.org\/10.1007\/s11548-012-0749-7\n\n.","journal-title":"Int J Comput Assist Radiol Surg"},{"key":"3843_CR25","doi-asserted-by":"publisher","first-page":"709","DOI":"10.2967\/jnumed.111.099531","volume":"53","author":"EH Dibble","year":"2012","unstructured":"Dibble EH, Alvarez AC, Truong MT, Mercier G, Cook EF, Subramaniam RM. 18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging. J Nucl Med. 2012;53:709\u201315. \nhttps:\/\/doi.org\/10.2967\/jnumed.111.099531\n\n.","journal-title":"J Nucl Med"},{"key":"3843_CR26","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ijrobp.2010.11.050","volume":"82","author":"KA Higgins","year":"2012","unstructured":"Higgins KA, Hoang JK, Roach MC, Chino J, Yoo DS, Turkington TG, et al. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value. Int J Radiat Oncol Biol Phys. 2012;82:548\u201353. \nhttps:\/\/doi.org\/10.1016\/j.ijrobp.2010.11.050\n\n.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3843_CR27","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.ejrad.2016.03.029","volume":"85","author":"W Shady","year":"2016","unstructured":"Shady W, Kishore S, Gavane S, Do RK, Osborne JR, Ulaner GA, et al. Metabolic tumor volume and total lesion glycolysis on FDG-PET\/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0. Eur J Radiol. 2016;85:1224\u201331. \nhttps:\/\/doi.org\/10.1016\/j.ejrad.2016.03.029\n\n.","journal-title":"Eur J Radiol"},{"key":"3843_CR28","first-page":"3495","volume":"35","author":"S Ogawa","year":"2015","unstructured":"Ogawa S, Itabashi M, Kondo C, Momose M, Sakai S, Kameoka S. Prognostic Value of Total Lesion Glycolysis Measured by 18F-FDG-PET\/CT in Patients with Colorectal Cancer. Anticancer Res. 2015;35:3495\u2013500.","journal-title":"Anticancer Res"},{"key":"3843_CR29","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.2967\/jnumed.115.170076","volume":"57","author":"YI Kim","year":"2016","unstructured":"Kim YI, Paeng JC, Cheon GJ, Suh KS, Lee DS, Chung JK, et al. Prediction of Posttransplantation Recurrence of Hepatocellular Carcinoma Using Metabolic and Volumetric Indices of 18F-FDG PET\/CT. J Nucl Med. 2016;57:1045\u201351. \nhttps:\/\/doi.org\/10.2967\/jnumed.115.170076\n\n.","journal-title":"J Nucl Med"},{"key":"3843_CR30","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s00259-011-1758-4","volume":"38","author":"SA Gulec","year":"2011","unstructured":"Gulec SA, Suthar RR, Barot TC, Pennington K. The prognostic value of functional tumor volume and total lesion glycolysis in patients with colorectal cancer liver metastases undergoing 90Y selective internal radiation therapy plus chemotherapy. Eur J Nucl Med Mol Imaging. 2011;38:1289\u201395. \nhttps:\/\/doi.org\/10.1007\/s00259-011-1758-4\n\n.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 1","key":"3843_CR31","doi-asserted-by":"publisher","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","volume":"50","author":"RL Wahl","year":"2009","unstructured":"Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(Suppl 1):122S\u201350S. \nhttps:\/\/doi.org\/10.2967\/jnumed.108.057307\n\n.","journal-title":"J Nucl Med"},{"key":"3843_CR32","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1097\/rlu.0000000000001040","volume":"41","author":"M Bailly","year":"2016","unstructured":"Bailly M, Venel Y, Orain I, Salame E, Ribeiro MJ. 18F-FDG PET in Liver Transplantation Setting of Hepatocellular Carcinoma: Predicting Histology? Clin Nucl Med. 2016;41:e126\u20139. \nhttps:\/\/doi.org\/10.1097\/rlu.0000000000001040\n\n.","journal-title":"Clin Nucl Med"},{"key":"3843_CR33","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.3748\/wjg.v21.i10.3049","volume":"21","author":"O Detry","year":"2015","unstructured":"Detry O, Govaerts L, Deroover A, Vandermeulen M, Meurisse N, Malenga S, et al. Prognostic value of (18)F-FDG PET\/CT in liver transplantation for hepatocarcinoma. World J Gastroenterol. 2015;21:3049\u201354. \nhttps:\/\/doi.org\/10.3748\/wjg.v21.i10.3049\n\n.","journal-title":"World J Gastroenterol"},{"key":"3843_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1432-2277.2012.01572.x","volume":"26","author":"SD Lee","year":"2013","unstructured":"Lee SD, Kim SH, Kim YK, Kim C, Kim SK, Han SS, et al. (18)F-FDG-PET\/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma. Transpl Int. 2013;26:50\u201360. \nhttps:\/\/doi.org\/10.1111\/j.1432-2277.2012.01572.x\n\n.","journal-title":"Transpl Int"},{"key":"3843_CR35","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1097\/RLU.0000000000001545","volume":"42","author":"CY Lin","year":"2017","unstructured":"Lin CY, Liao CW, Chu LY, Yen KY, Jeng LB, Hsu CN, et al. Predictive Value of 18F-FDG PET\/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation. Clin Nucl Med. 2017;42:e183\u2013e7. \nhttps:\/\/doi.org\/10.1097\/RLU.0000000000001545\n\n.","journal-title":"Clin Nucl Med"},{"key":"3843_CR36","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.2967\/jnumed.112.116426","volume":"54","author":"WP Fendler","year":"2013","unstructured":"Fendler WP, Philippe Tiega DB, Ilhan H, Paprottka PM, Heinemann V, Jakobs TF, et al. Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer. J Nucl Med. 2013;54:1202\u20138. \nhttps:\/\/doi.org\/10.2967\/jnumed.112.116426\n\n.","journal-title":"J Nucl Med"},{"key":"3843_CR37","doi-asserted-by":"publisher","unstructured":"Soydal C, Kucuk ON, Gecim EI, Bilgic S, Elhan AH. The prognostic value of quantitative parameters of 18F-FDG PET\/CT in the evaluation of response to internal radiation therapy with yttrium-90 in patients with liver metastases of colorectal cancer. Nucl Med Commun 2013;34:501-506. doi:\nhttps:\/\/doi.org\/10.1097\/MNM.0b013e32835f9427\n\n.","DOI":"10.1097\/MNM.0b013e32835f9427"},{"key":"3843_CR38","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s00259-012-2149-1","volume":"39","author":"I Zerizer","year":"2012","unstructured":"Zerizer I, Al-Nahhas A, Towey D, Tait P, Ariff B, Wasan H, et al. The role of early (1)(8)F-FDG PET\/CT in prediction of progression-free survival after (9)(0)Y radioembolization: comparison with RECIST and tumour density criteria. Eur J Nucl Med Mol Imaging. 2012;39:1391\u20139. \nhttps:\/\/doi.org\/10.1007\/s00259-012-2149-1\n\n.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3843_CR39","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00259-014-2935-z","volume":"42","author":"A Sabet","year":"2015","unstructured":"Sabet A, Meyer C, Aouf A, Sabet A, Ghamari S, Pieper CC, et al. Early post-treatment FDG PET predicts survival after 90Y microsphere radioembolization in liver-dominant metastatic colorectal cancer. Eur J Nucl Med Mol Imaging. 2015;42:370\u20136. \nhttps:\/\/doi.org\/10.1007\/s00259-014-2935-z\n\n.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3843_CR40","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1245\/s10434-013-3449-9","volume":"21","author":"M Hagness","year":"2014","unstructured":"Hagness M, Foss A, Egge TS, Dueland S. Patterns of recurrence after liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg Oncol. 2014;21:1323\u20139. \nhttps:\/\/doi.org\/10.1245\/s10434-013-3449-9\n\n.","journal-title":"Ann Surg Oncol"},{"key":"3843_CR41","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1148\/rg.242025724","volume":"24","author":"V Kapoor","year":"2004","unstructured":"Kapoor V, McCook BM, Torok FS. An introduction to PET-CT imaging. Radiographics. 2004;24:523\u201343. \nhttps:\/\/doi.org\/10.1148\/rg.242025724\n\n.","journal-title":"Radiographics"},{"key":"3843_CR42","doi-asserted-by":"publisher","DOI":"10.2349\/biij.2.4.e60","volume":"2","author":"C Pettinato","year":"2006","unstructured":"Pettinato C, Nanni C, Farsad M, Castellucci P, Sarnelli A, Civollani S, et al. Artefacts of PET\/CT images. Biomedical Imaging and Intervention Journal. 2006;2:e60. \nhttps:\/\/doi.org\/10.2349\/biij.2.4.e60\n\n.","journal-title":"Biomedical Imaging and Intervention Journal"},{"key":"3843_CR43","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fonc.2014.00205","volume":"4","author":"A Chi","year":"2014","unstructured":"Chi A, Nguyen NP. 4D PET\/CT as a Strategy to Reduce Respiratory Motion Artifacts in FDG-PET\/CT. Front Oncol. 2014;4:205. \nhttps:\/\/doi.org\/10.3389\/fonc.2014.00205\n\n.","journal-title":"Front Oncol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-017-3843-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3843-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3843-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T22:59:09Z","timestamp":1514415549000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-017-3843-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,12]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["3843"],"URL":"https:\/\/doi.org\/10.1007\/s00259-017-3843-9","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,12]]}}}